MYX mayne pharma group limited

Ann: 2022 Half Year Investor Presentation, page-39

  1. 1,913 Posts.
    lightbulb Created with Sketch. 165
    There is a good research note by Bellpotter its on the Belldirect website released on the 27/02/2022 it has the fitting name of " Darkest before Dawn" they have reduced their recommendation from buy to hold and have a 12 month target of only 26c it was above 50c previously
    They believe the MCS business maybe valued more than the entire MC of MYX
    "The analysis is intended to highlight the underlying value in MCS. The analysis suggests that on a sum of parts basis, MCS maybe valued (in a transaction) at greater than 15x CM or ~A$675m being well ahead of the groups now modest market capitalisation. The Board is probably considering ways to unlock this value for shareholders, however, in our view the sale of MCS would have to be a last resort."
    Last edited by joca: 28/02/22
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.02
Change
0.020(0.40%)
Mkt cap ! $407.8M
Open High Low Value Volume
$5.05 $5.09 $4.96 $774.1K 154.0K

Buyers (Bids)

No. Vol. Price($)
3 3317 $4.99
 

Sellers (Offers)

Price($) Vol. No.
$5.04 1291 1
View Market Depth
Last trade - 16.10pm 25/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.